Epstein Secrets

ine Use. The Washington Post (4/22, Al, McGinley, Sun, 10.52M) reports, "Federal health authorities are leaning toward recommending that use of the Johnson & Johnson coronavirus vaccine resume, possibly as soon as this weekend - a move that would include a new warning about a rare complication involving blood cl

can and Pacific Islander community. Collins said it 'affirms our commitment to stand with' them against hate crimes." The New York Daily News (4/22, Sommerfeldt, 2.51M) reports that Schumer "said the rare bipartisan feat is proof the usually gridlocked chamber can 'work to solve important issues." USA Toda

rt to overcome the 60-vote threshold. And even some Senate Democrats have yet to say whether they would support it." The New York Daily News (4/22, Sommerfeldt, 2.51M) reports Senate Minority Leader McConnell "has made clear he will direct his caucus to strongly oppose any D.C. statehood effort." USA Today

. The New York Post <https://nypost.corn/2020/07/30/johnson-johnson-starts-human-vaccine-trials-after-monkey- study/> (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmaker

New York Daily News <https://vvww.nydailynews.corn/news/politics/ny-michael-cohen-trump-book-20200730- 37pfhj3c55dk3felo3exhummoa-story.html> (7/30, Sommerfeldt, 2.52M), among other outlets, also report the story. Other Washington News GOP Legislators Quick To Reject Trump's Floating Of Delay In November E

ication, 8.41M) also have reports. J&J Says It Should Have Enough Doses For More Than 20M By End Of March. The Hill (2/22, Sullivan, 5.69M) reports Johnson & Johnson said Monday that it "plans to have enough doses of its vaccine for more than 20 million Americans by the end of March" if its vaccine is authorized

ats and Republicans on the panel appeared to treat his confirmation almost as a foregone conclusion." EFTA00148037 The New York Daily News (2/22, Sommerfeldt, 2.51M) reports that Garland will "become the third Jewish attorney general in American history if confirmed by the Senate." He told the committee,

uccia, Subscription Publication, 8.41M), Politico (1/26, Cancryn, Roubein, 6.73M), and The Hill (1/26, Sullivan, Samuels, 5.69M) also have reports. Johnson & Johnson Expects To Report Vaccine Data Next Week. Reuters (1/26, Mishra, O'Donnell) reports that on Tuesday, Johnson & Johnson "said it expected to report

n's governors on Tuesday and pledged to provide states with firm vaccine allocations three weeks ahead of delivery." The New York Daily News (1/26, Sommerfeldt, Slattery, 2.51M) reports, "Many state leaders complained that the Trump administration had kept them in the dark about how many shots they could ex

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

rves the purposes of confinement." The New York Times (7/30, Weiser, 18.61M), New York Post (7/30, Feuerherd, 4.57M) and New York Daily News (7/30, Sommerfeldt, 2.52M), among other outlets, also report the story. OTHER WASHINGTON NEWS GOP Legislators Quick To Reject Trump's Floating Of Delay In November El

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

rves the purposes of confinement." The New York Times (7/30, Weiser, 18.61M), New York Post (7/30, Feuerherd, 4.57M) and New York Daily News (7/30, Sommerfeldt, 2.52M), among other outlets, also report the story. OTHER WASHINGTON NEWS GOP Legislators Quick To Reject Trump's Floating Of Delay In November El